FDA action against 23andMe doesn’t signal the end for personal genomics

Image via Genomics Law Report.

Last Monday, the U.S. Food and Drug Administration posted a letter on its website demanding that genetic testing company 23andMe stop marketing its popular home genome testing kit until it receives marketing clearance from the agency.

Since then, many have wondered if this was the FDA’s long-awaited first step in the regulation of direct-to-consumer genetic testing. But the FDA’s cease and desist letter doesn’t signal the end of personal genomics, as many have speculated. Rather, their action marks a new era for regulating fast-moving technologies, the rules of which are likely to be written as a result of this particular case.

“But inconsistencies are not just a problem for 23andMe,” writes the Genomics Law Report’s Jennifer K. Wagner. “They plague the FDA in this area too. Because the FDA has been ignoring personal genetic/omic analyses for ancestry (e.g., Ancestry.com DNA, LLC uses the same basic chip as 23andMe, Inc. as part of their ancestry analysis), the spit kit itself cannot be used as the basis for claiming the PGS service is within FDA oversight of ‘medical devices.’ Some have said that the FDA has no interest in regulating return of raw data results, interpretations for ancestry purposes, or traits like earwax. Yet on what basis is that decision being drawn and by whom?”

Read the full, original story here: The Sky is Falling for Personal Genomics! Oh, nevermind. It’s just a cease & desist letter from the FDA to 23andMe.

Additional Resources:

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend